Publication: Global glycosphingolipid analysis in urine and plasma of female Fabry disease patients
Global glycosphingolipid analysis in urine and plasma of female Fabry disease patients
Date
Date
Date
Citations
Heywood, W. E., Doykov, I., Spiewak, J., Hallqvist, J., Mills, K., & Nowak, A. (2019). Global glycosphingolipid analysis in urine and plasma of female Fabry disease patients. Biochimica et Biophysica Acta. Molecular Basis of Disease, 1865(10), 2726–2735. https://doi.org/10.1016/j.bbadis.2019.07.005
Abstract
Abstract
Abstract
Fabry disease (FD) is an X-linked lysosomal storage disorder caused by deficiency of α-galactosidase-A, which results in accumulation of the glycosphingolipid (GSL) globotriaosylceramide (Gb). Gb and globotriaosylsphingosine (lyso-Gb) levels in plasma and urine are used routinely for diagnosis and treatment monitoring. FD female patients are problematic to diagnose and to predict when to begin treatment. Further biomarkers are needed to detect pre-symptomatic females that will develop the chronic symptoms associated with FD. A LC-MS/M
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Journal/Series Title
Journal/Series Title
Journal/Series Title
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Metrics
Downloads
Views
Citations
Heywood, W. E., Doykov, I., Spiewak, J., Hallqvist, J., Mills, K., & Nowak, A. (2019). Global glycosphingolipid analysis in urine and plasma of female Fabry disease patients. Biochimica et Biophysica Acta. Molecular Basis of Disease, 1865(10), 2726–2735. https://doi.org/10.1016/j.bbadis.2019.07.005